{podcast} Thursday’s wobble in US stock markets (ex-Nasdaq) proved to be just that, bank shares driving the rebound just as they had led Thursday’s decline and in front of Tuesday’s start of bank earnings season. Ostensibly positive news of Gilead’s Remdesivir drug in reducing mortality rates was also widely cited Limited moves in currencies Friday though squinting though some of the intra-day noise and looking at markets over the course of last week, the negative correlation between risk sentiment and the USD is intact, as too the positive one vis-à-vis AUD. It’s a very big week ahead. {charts} The S&P 500 on F ... (full story)